Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report

被引：13
|
作者：
Torcuator, Roy [1 ]
Zuniga, Richard [1 ]
Loutfi, Randa [2 ]
Mikkelsen, Tom [1 ,3 ]
机构：
[1] Henry Ford Hlth Syst, Hermelin Brain Tumor Ctr, Dept Neurosurg, Detroit, MI 48202 USA
[2] Henry Ford Hlth Syst, Hermelin Brain Tumor Ctr, Dept Med Oncol, Detroit, MI 48202 USA
[3] Henry Ford Hlth Syst, Hermelin Brain Tumor Ctr, Dept Neurol, Detroit, MI 48202 USA
来源：
JOURNAL OF NEURO-ONCOLOGY | 2009年 / 93卷 / 03期
关键词：
Brainstem; Glioma; Diffuse chemotherapy; Bevacizumab; Irinotecan; CHILDREN; CHEMOTHERAPY; RADIOTHERAPY; TRIAL;
D O I：
10.1007/s11060-008-9782-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Diffuse brainstem glioma carries a dismal prognosis. The current cornerstone of treatment is radiation therapy. Chemotherapy appears to be ineffective and the role of this treatment in the recurrent or progressive setting is not known. Bevacizumab and irinotecan have been reported to have shown radiographic response and improvement in progression-free survival among patients with malignant supratentorial gliomas. In this paper, we report our experience in an adult patient with progressive diffuse brainstem glioma treated with bevacizumab and irinotecan.
引用
收藏
页码：409 / 412
页数：4
相关论文
共 50 条
  • [21] Treatment of Children with Diffuse Intrinsic Pontine Gliomas with Chemoradiotherapy Followed by a Combination of Temozolomide, Irinotecan, and Bevacizumab
    Zaky, Wafik
    Wellner, Michael
    Brown, Robert J.
    Blueml, Stefan
    Finlay, Jonathan L.
    Dhall, Girish
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2013, 30 (07) : 623 - 632
  • [22] Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report
    Castelli, Barbara
    Fonte, Carla
    Guidi, Milena
    Tellini, Marco
    Di Nicola, Marco
    Iacono, Alessandro
    Buccoliero, Anna Maria
    Greto, Daniela
    Genitori, Lorenzo
    Sardi, Iacopo
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [23] THE ROLE OF HYPOFRACTIONATION RADIOTHERAPY FOR DIFFUSE INTRINSIC BRAINSTEM GLIOMA IN CHILDREN: A PILOT STUDY
    Janssens, Geert O. R. J.
    Gidding, Corrie E. M.
    Van Lindert, Erik J.
    Oldenburger, Foppe R.
    Erasmus, Corrie E.
    Schouten-Meeteren, Antoinette Y. N.
    Kaanders, Johannes H. A. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (03): : 722 - 726
  • [24] Bevacizumab and irinotecan in the treatment of recurrent malignant gliomas
    de Groot, John F.
    Yung, Wai Kwan A. Fred
    CANCER JOURNAL, 2008, 14 (05) : 279 - 285
  • [25] Durable Complete Remission of a Brainstem Glioma Treated with a Combination of Bevacizumab and Cetuximab
    Gasent Blesa, Joan Manel
    Blasco Molla, Sara
    Fonfria Esparcia, Maria
    Sempere Ortells, Jose Miguel
    Peris Godoy, Miguel
    Munilla Das, Adrian
    Mancheno Magan, Balbino
    Provencio Pulla, Mariano
    Luis Sanchez, Jose
    Laforga Canales, Juan Bautista
    Alberola Candel, Vicente
    CASE REPORTS IN ONCOLOGY, 2012, 5 (03): : 676 - 681
  • [26] Risk of Adverse Vascular Events in Patients with Malignant Glioma Treated with Bevacizumab Plus Irinotecan: A Systematic Review and Meta-Analysis
    Dong, Jiawei
    Meng, Xiangqi
    Li, Siyi
    Chen, Qun
    Shi, Lei
    Jiang, Chuanlu
    Cai, Jinquan
    WORLD NEUROSURGERY, 2019, 130 : E236 - E243
  • [27] Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution
    Chiang, Kuo-Liang
    Chang, Kai-Ping
    Lee, Yi-Yen
    Huang, Pin-I
    Hsu, Ting-Rong
    Chen, Yi-Wei
    Chang, Feng-Chi
    Wong, Tai-Tong
    CHILDS NERVOUS SYSTEM, 2010, 26 (08) : 1035 - 1041
  • [28] Treatment of adult brainstem glioma with combined antiangiogenic therapy: a case report and literature review
    Yu, Dongdong
    Han, Guang
    Liu, Huali
    Gao, Likun
    Verma, Vivek
    ONCOTARGETS AND THERAPY, 2019, 12 : 1333 - 1339
  • [29] Irinotecan and bevacizumab in progressive primary brain tumors, an evaluation of efficacy and safety
    Kang, Tyler Y.
    Jin, Tony
    Elinzano, Heinrich
    Peereboom, David
    JOURNAL OF NEURO-ONCOLOGY, 2008, 89 (01) : 113 - 118
  • [30] Achievement of Three Year Remission with Bevacizumab and Irinotecan in Recurrent Glioblastoma Multiforme: A Case Report
    Vivekanandarajah, Abhirami
    Krishnarasa, Balakumar
    Mourad, Mervat
    Aoun, Nelly
    Odaimi, Marcel
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2011, 5 : 15 - 21
12345